Receptor-Mediated Internalization of Fluorescent Chemotactic Peptide by Human Neutrophils-Reference-Cited by-同舟云学术

Receptor-Mediated Internalization of Fluorescent Chemotactic Peptide by Human Neutrophils

Published:1979-09-28 Issue:4413 Volume:205 Page:1412-1414
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Niedel James E.¹²,Kahane Itzhak¹,Cuatrecasas Pedro¹

Affiliation:

1. Department of Molecular Biology, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709

2. Duke University Medical Center, Durham, North Carolina 27713

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference16 articles.

1. ASWANIKUMAR, S, DEMONSTRATION OF A RECEPTOR ON RABBIT NEUTROPHILS FOR CHEMOTACTIC PEPTIDES, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 74: 810 (1977).

2. BECKER, E.L., SOME INTERRELATIONS OF NEUTROPHIL CHEMOTAXIS, LYSOSOMAL ENZYME-SECRETION, AND PHAGOCYTOSIS AS REVEALED BY SYNTHETIC PEPTIDES, AMERICAN JOURNAL OF PATHOLOGY 85: 385 (1976).

3. CHENOWETH, D.E., DEMONSTRATION OF SPECIFIC C5A RECEPTOR ON INTACT HUMAN POLYMORPHONUCLEAR LEUKOCYTES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 75: 3943 (1978).

4. HATCH, G.E., JOURNAL OF EXPERIMENTAL MEDICINE 147: 182 (1978).

5. ISERSKY, C, TRIGGERING OF CULTURED NEOPLASTIC MAST-CELLS BY ANTIBODIES TO RECEPTOR FOR IGE, JOURNAL OF IMMUNOLOGY 121: 549 (1978).

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A fluorescent photoaffinity probe for formyl peptide receptor 1 labelling in living cells;RSC Chemical Biology;2023

2. Targeted Delivery of a Ligand–Drug Conjugate via Formyl Peptide Receptor 1 through Cholesterol-Dependent Endocytosis;Molecular Pharmaceutics;2019-05-08

3. Synthesis and evaluation of a [18F]formyl–Met–Leu–Phe derivative: A positron emission tomography imaging probe for bacterial infections;Bioorganic & Medicinal Chemistry Letters;2018-09

4. Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents;Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches;2018

5. Preclinical model for identification of therapeutic targets for CML offers clues for handling imatinib resistance;Biomedicine & Pharmacotherapy;2015-07